> >

Drug companies avert landmark opioids trial as talks on $48 billion settlement set to resume

Reuters India Monday, 21 October 2019
Four large drug companies could resume talks on Tuesday to try to reach a $48 billion settlement of all opioid litigation against them, after agreeing with two Ohio counties to a $260 million deal to avert the first federal trial over their role in the U.S. opioid epidemic.

You Might Like

Recent related videos from verified sources

Charles Schwab to Reportedly Purchase TD Ameritrade [Video]Charles Schwab to Reportedly Purchase TD Ameritrade

Charles Schwab to Reportedly Purchase TD Ameritrade . On Nov. 21, numerous sites reported that Charles Schwab is in talks to buy TD Ameritrade. The deal would reportedly be worth $26 billion...

Credit: Wibbitz Top Stories     Duration: 01:11Published

Opioid Use May Negatively Impact Sleep [Video]Opioid Use May Negatively Impact Sleep

Long-term use of prescription opioids may cause those who rely on them for pain relief to lose sleep . The American Academy of Sleep Medicine (AASM) warns that the drug may reduce sleep quality. The..

Credit: Wochit News     Duration: 00:33Published

Tweets about this

Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2019 newsR Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest